Fig. 3
From: Sex differences in adult asthma and COPD therapy: a systematic review
Response to pharmacological treatments in asthma A and COPD B according to specific outcomes and number of evidences as resulting from the studies included in the systematic review. The greater response of a gender vs. the other one was reported when a statistically significant (P < 0.05) superiority was detected for a specific treatment. COPD chronic obstructive pulmonary disease, FeNO exhaled nitric oxide, ICS inhaled corticosteroids, LABA long-acting β2-adrenoceptor agonist, LAMA long-acting muscarinic antagonist, PDE4 phosphodiesterase 4, SABA short-acting β2-adrenoceptor agonist